Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada

Authors

C Quach
Rodica Gilca (ORCID: https://orcid.org/0000-0002-8558-3967)
Maude Paquette (ORCID: https://orcid.org/0009-0006-5751-7715)
Denis Talbot (ORCID: https://orcid.org/0000-0003-0431-3314)
Charles-Antoine Guay (ORCID: https://orcid.org/0009-0002-9774-9095)
Manale Ouakki (ORCID: https://orcid.org/0000-0002-3068-4373)
D M Skowronski
Nicholas Brousseau
Sara Carazo
Jesse Papenburg

Institutions

Montreal Children's Hospital (CA)
Centre Hospitalier Universitaire Sainte-Justine (CA)
BC Centre for Disease Control (CA)
Centre hospitalier universitaire de Québec (CA)
Institut National de Santé Publique du Québec (CA)
Université Laval (CA)
McGill University (CA)
Université de Montréal (CA)

Publication Details

Journal: The Lancet Regional Health - Americas
Published: 2026-03-11
DOI: https://doi.org/10.1016/j.lana.2026.101448
Primary Topic: Respiratory viral infections research
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Institut National de Santé Publique du Québec
Ministère de la Santé et des Services sociaux
Ministère de la Santé

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada

C Quach, Rodica Gilca, Maude Paquette, Denis Talbot et al.

Mar 11, 2026

The Lancet Regional Health - Americas

Respiratory viral infections research

article

Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada

C Quach, Rodica Gilca, Maude Paquette, Denis Talbot, Charles-Antoine Guay, Manale Ouakki, D M Skowronski, Nicholas Brousseau, Sara Carazo, Jesse Papenburg

March 11, 2026article en

Abstract

No abstract available for this paper.

The Lancet Regional Health - AmericasVol. 57

Montreal Children's Hospital (CA), Centre Hospitalier Universitaire Sainte-Justine (CA), BC Centre for Disease Control (CA), Centre hospitalier universitaire de Québec (CA), Institut National de Santé Publique du Québec (CA), Université Laval (CA), McGill University (CA), Université de Montréal (CA)

Institut National de Santé Publique du Québec, Ministère de la Santé et des Services sociaux, Ministère de la Santé

Openalex Percentile: Top 27%

Respiratory viral infections research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada — C Quach, Rodica Gilca, et al. · The Lancet Regional Health - Americas (2026) | TGRS Research Map | TGRS